整形科

订阅

MedSci主页 / 所有栏目 / 整形科

梅斯医学参与第二届国际淋巴学研讨会全面报道

2017-02-06 MedSci MedSci原创

淋巴学刘宁飞
关注

会议通知尊敬的同道们，大家好！第二届国际淋巴学研讨会-高峰对话暨第16界上海国际整形美容会议淋巴分会将于2017年3月18-19日在上海召开。诚邀你们参会。此次大会邀请了国际淋巴学创始人之一M Witte教授，CDT治疗的创始人E Foeldi教授，淋巴外科领军者C Becker和J Maegawa 教授，淋巴水肿治疗专家Schingale等国际顶尖的淋巴学者。本次会


会议通知
尊敬的同道们，
大家好！
第二届国际淋巴学研讨会-高峰对话暨第16界上海国际整形美容会议淋巴分会将于2017年3月18-19日在上海召开。诚邀你们参会。此次大会邀请了国际淋巴学创始人之一M Witte教授，CDT治疗的创始人E Foeldi教授，淋巴外科领军者C Becker和J Maegawa 教授，淋巴水肿治疗专家Schingale等国际顶尖的淋巴学者。本次会议聚焦淋巴水肿的临床新进展，包括淋巴系统影像学诊断，显微淋巴外科和淋巴水肿综合消肿治疗（CDT）的成就。本次论坛将搭建临床淋巴学学术交流平台，为你们提供与国际顶级大师面对面进行交流的机会，与E Foeldi淋巴医院经验丰富治疗师当面请教，机会非常难得。本次会议对治疗师和护士实行免注册费，全程参加者可以获得国家继续教育一类学分10分，名额限定在前100名。希望你们尽早从会议网站报名（无需交注册费），欲发言者可以从会议网站递交发言摘要。

中华医学会淋巴水肿学组组长
第二届国际淋巴学研讨会主席
2017年1月16日




会议时间：2017年3月18-19日
会议地址：上海天城大酒店，上海国际会议中心
联系人：陈佳佳 15021933970
更多信息请登录会议网站http://www.2017sh-lymphedema.com/


版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1994740, encodeId=abc11994e4022, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Wed Dec 20 02:09:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276961, encodeId=73ca12e69616b, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Feb 08 04:09:00 CST 2017, time=2017-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580291, encodeId=e439158029180, content=<a href='/topic/show?id=a00065950b4' target=_blank style='color:#2F92EE;'>#淋巴学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65950, encryptionId=a00065950b4, topicName=淋巴学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50f116619411, createdName=more is better!, createdTime=Wed Feb 08 04:09:00 CST 2017, time=2017-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=174798, encodeId=640b1e479870, content=很好，不错，以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Tue Feb 07 19:20:33 CST 2017, time=2017-02-07, status=1, ipAttribution=)]
    2017-12-20 kcb069

    #研讨会#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1994740, encodeId=abc11994e4022, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Wed Dec 20 02:09:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276961, encodeId=73ca12e69616b, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Feb 08 04:09:00 CST 2017, time=2017-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580291, encodeId=e439158029180, content=<a href='/topic/show?id=a00065950b4' target=_blank style='color:#2F92EE;'>#淋巴学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65950, encryptionId=a00065950b4, topicName=淋巴学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50f116619411, createdName=more is better!, createdTime=Wed Feb 08 04:09:00 CST 2017, time=2017-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=174798, encodeId=640b1e479870, content=很好，不错，以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Tue Feb 07 19:20:33 CST 2017, time=2017-02-07, status=1, ipAttribution=)]
    2017-02-08 一闲

    #梅斯#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1994740, encodeId=abc11994e4022, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Wed Dec 20 02:09:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276961, encodeId=73ca12e69616b, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Feb 08 04:09:00 CST 2017, time=2017-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580291, encodeId=e439158029180, content=<a href='/topic/show?id=a00065950b4' target=_blank style='color:#2F92EE;'>#淋巴学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65950, encryptionId=a00065950b4, topicName=淋巴学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50f116619411, createdName=more is better!, createdTime=Wed Feb 08 04:09:00 CST 2017, time=2017-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=174798, encodeId=640b1e479870, content=很好，不错，以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Tue Feb 07 19:20:33 CST 2017, time=2017-02-07, status=1, ipAttribution=)]
    2017-02-08 more is better!

    #淋巴学#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1994740, encodeId=abc11994e4022, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Wed Dec 20 02:09:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276961, encodeId=73ca12e69616b, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Feb 08 04:09:00 CST 2017, time=2017-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580291, encodeId=e439158029180, content=<a href='/topic/show?id=a00065950b4' target=_blank style='color:#2F92EE;'>#淋巴学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65950, encryptionId=a00065950b4, topicName=淋巴学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50f116619411, createdName=more is better!, createdTime=Wed Feb 08 04:09:00 CST 2017, time=2017-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=174798, encodeId=640b1e479870, content=很好，不错，以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Tue Feb 07 19:20:33 CST 2017, time=2017-02-07, status=1, ipAttribution=)]
    2017-02-07 李东泽

    很好，不错，以后会多学习

    0

相关资讯

梅斯作为媒体参与第二届国际淋巴学研讨会于17年3月18-19日在沪举行

尊敬的同道们：  第二届国际淋巴学研讨会-高峰对话将于2017年3月18-19日在上海召开。此次大会邀请了国际淋巴学会秘书长M Wittle教授,CDT治疗的创始人E Foeldi教授，淋巴而是看人领军者C Becker教授等国际顶尖的淋巴学者。会议聚焦淋巴水肿的临床新进展，包括淋巴系统影像学诊断，显微淋巴外科和淋巴水肿综合消肿治疗（CDT）的成就。本次论坛将搭建临床淋巴学学术交流平台，